Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2003
10/29/2003EP1356809A1 Sustained release preparations
10/29/2003EP1356806A1 A pharmaceutical composition for treating dysmenorrhea and premature labor
10/29/2003EP1356285A2 Differentially expressed epitopes and uses thereof
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
10/29/2003EP1355924A2 Armed peptides
10/29/2003EP1355919A2 Molecules with extended half-lives, compositions and uses thereof
10/29/2003EP1355877A1 Process of obtaining compositions of stable lutein and lutein derivatives
10/29/2003EP1355682A2 Hydrogel wound dressing and the method of making and using the same
10/29/2003EP1355676A2 Protecting therapeutic compositions from host-mediated inactivation
10/29/2003EP1355675A1 Anti-tumor compounds
10/29/2003EP1355674A2 Oligo or polyalkylene glycol-coupled thrombin inhibitors
10/29/2003EP1355673A2 Multivalent meningococcal polysaccharide-protein conjugate vaccine
10/29/2003EP1355672A2 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
10/29/2003EP1355671A2 Water-soluble polymer conjugates of triazine derivatives
10/29/2003EP1355670A2 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane destabilisers
10/29/2003EP1355659A2 Use of compositions containing pdgf-bb for promoting angiogenesis
10/29/2003EP1355652A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
10/29/2003EP1355641A2 Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
10/29/2003EP1355636A1 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same
10/29/2003EP1355635A1 New film coating
10/29/2003EP1355634A2 Sn-38 lipid complexes and methods of use
10/29/2003EP1355633A1 New film coating
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1355628A2 Stabilised polymeric aerosols for pulmonary gene delivery
10/29/2003EP1355626A2 Veterinary dermatologic composition
10/29/2003EP1355588A2 Delivery of therapeutic capable agents
10/29/2003EP1355566A2 Local regional chemotherapy and radiotherapy using in situ hydrogel
10/29/2003EP1251853B1 Transdermal therapeutic system for the administration of zaleplon
10/29/2003EP1214056B1 Topical suspension formulations containing ciprofloxacin and dexamethasone
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003EP1161230B1 Transdermal therapy system and method for producing the same
10/29/2003EP1105096B1 Injectable aqueous dispersions of propofol
10/29/2003EP1011692B1 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY
10/29/2003EP0984788B1 Pharmaceutical compositions of peptides having low solubility in physiological medium
10/29/2003EP0941122B1 Compositions for polynucleotide delivery
10/29/2003EP0923566B1 High molecular weight polymer-based prodrugs
10/29/2003EP0892632B1 Compositions useful in the phototherapeutic treatment of proliferative skin disorders
10/29/2003EP0796403B1 Functionalized nanotubes
10/29/2003EP0594803B1 Composition for reducing side-effects of a drug
10/29/2003CN1452650A Process for preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
10/29/2003CN1452636A Human monoclonal antibodies to dendritis cells
10/29/2003CN1452617A Acid-sensitive compounds, preparation and uses thereof
10/29/2003CN1452613A Amorphous torasemide modification
10/29/2003CN1452498A 药物活性化合物 Pharmaceutically active compounds
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1452481A Pectin film compositions
10/29/2003CN1452479A Stable pharmaceutical solution formulations for pressurised metered dose inhalers
10/29/2003CN1452478A Pre-formed sheet devices suitable for topical application
10/29/2003CN1451438A Sparagin injection using xylitol as isosmotic adjusting agent
10/29/2003CN1451389A Agent for promoting cell activation for external use
10/29/2003CN1451381A Process for preparing medicinal preparation contg. sulfonium methyl methionine chloride
10/29/2003CN1451378A ÔÇ£MaolansuÔÇØ fat emulsion as antineoplastic medicine and preparing process
10/29/2003CN1451373A Insoluble medicine tablet and preparing process thereof
10/29/2003CN1125654C Methods of preparing gas and gaseous precursor filled microspheres
10/29/2003CN1125653C Pharmaceutical formulations containing voriconazole
10/29/2003CN1125650C Human immunization strengthening medicine
10/29/2003CN1125635C Enrofloxacine injection or infusion solutions
10/28/2003US6639069 Method of preparing and uses of cucurbituril devices
10/28/2003US6639060 DNA segment encoding a receptor protein related to the erbB proto-oncogene family which previously has not been known; tool for screening for anticancer agents
10/28/2003US6639014 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
10/28/2003US6638987 Azeotrope-like compositions of tetrafluoroethane, pentafluoropropane and water
10/28/2003US6638981 Topical compositions and methods for treating pain
10/28/2003US6638978 Glycerol monoester of lauric acid, mixture of capric and caprylic acids, carrier which optionally contains chelating agent
10/28/2003US6638966 Use of melatonin analogues for induction of general anesthesia
10/28/2003US6638948 A free-flowing, amorphous paroxetine hydrochloride composition suitable as a therapeutic agent for premature ejaculation can be prepared by dissolving paroxetine free base in a hydrochloric acid-ethanol solution followed by
10/28/2003US6638918 Chitosan compositions
10/28/2003US6638917 Reducing adhesion
10/28/2003US6638913 Concentrated injection and infusion solution for intravenous administration
10/28/2003US6638906 Amphiphilic polymers and polypeptide conjugates comprising same
10/28/2003US6638767 Methods for delivering compounds into a cell
10/28/2003US6638756 Chimeric cell-targeting pathogenic organism and method of therapeutic use
10/28/2003US6638740 Chromatography, elution, ion exchanging
10/28/2003US6638537 Emulsification with a long chain polymer surfactant and a short chain fatty acid surfactant; thermodynamic stability
10/28/2003US6638530 N-(2-anilino)- and pyridino- substituents; mixed with polyoxyethylene glycol and surfactant, mineral acid salt of amino acid or propylene carbonate; absorbability; anticarcinogenic agents, immunosuppressants
10/28/2003US6638525 Pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
10/28/2003US6638523 Administering carnosic acid and/or carnosol
10/28/2003US6638522 Carrier comprising solubilizing amount of propylene glycol monoester of C6-C18 fatty acid and nonionic surfactant
10/28/2003US6638521 Oral liquid mucoadhesive compositions
10/28/2003US6638509 Bound through spacer comprising maleimide-derived polyalkylene glycol and dipeptide; antitumor and anticarcinogenic agents
10/28/2003US6638508 Drug delivery; therapy for liver disorders
10/28/2003US6638504 Methods for treating cancer
10/28/2003US6638500 Polyol-IFN-βconjugates modified at Cys-17 and composition containing same
10/28/2003US6638499 A nitrogen group containing linkage which is attached one end with a polyoxyalkylene glycol polymer and other end is coupled with a drug; useful for drug delivery
10/28/2003US6638495 Stabilized preparation for use in metered dose inhalers
10/28/2003US6638494 Iron hydroxide, ferric hydrate, iron oxide, iron mixed oxide or iron; di- or polycarboxylic acid stabilizer; aggregation prevention; antitumor and contrast agents; immune boosters, magnetic resonance imaging, cell fusion, gene transfer
10/28/2003US6637437 Cell-culture and polymer constructs
10/28/2003CA2342309C New solid dose form of nanoparticulate naproxen
10/28/2003CA2283939C Non-antigenic branched polymer conjugates
10/28/2003CA2263297C Inhibiting undesirable taste in oral compositions
10/28/2003CA2257890C Liquisolid systems and methods of preparing same
10/28/2003CA2155085C The preparation of colloidal aqueous solutions of active substances of low solubility
10/28/2003CA2139505C Precipitation of one or more active compounds in situ
10/28/2003CA2137265C Palatable pharmaceutical compositions
10/28/2003CA2118010C Antibodies specific for carcinoma-associated antigens
10/28/2003CA2103487C Delayed-release form for pharmaceutical active compounds
10/28/2003CA2098667C The production of solid pharmaceutical depot forms
10/28/2003CA2073353C Glycerol-derived non ionic amphiphilic compounds, a process for their preparation, corresponding intermediary compounds and compositions containing said compounds
10/23/2003WO2003087824A2 Charge-balanced chemoselective linkers
10/23/2003WO2003087821A2 Method for cleaving and deglycosylating antibodies to promote ligand binding
1 ... 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 ... 1712